Clinically important drug-disease interactions and their prevalence in older adults

Clinical Therapeutics

Volumn 28, Issue 8, 2006, Pages 1133-1143

  Lindblad, Catherine I ^a,b   Hanlon, Joseph T ^c,d,e   Gross, Cynthia R ^a   Sloane, Richard J ^f   Pieper, Carl F ^f,g   Hajjar, Emily R ^h   Ruby, Christine M ^c,e   Schmader, Kenneth E ^f,g,i   Multidisciplinary Consensus Panel, ^j  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Geriatric Research   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF THE SCIENCES   (United States)

ⁱ DURHAM VA MEDICAL CENTER   (United States)

^j NONE

more..

Author keywords

aged; drug disease interactions; epidemiology

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETHANECHOL; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; HYPNOTIC SEDATIVE AGENT; IRON DERIVATIVE; METHYLPHENIDATE; MUSCLE RELAXANT AGENT; NALIDIXIC ACID; NIFEDIPINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PHENYTOIN; PROCAINAMIDE; PROPRANOLOL; PSEUDOEPHEDRINE; QUINIDINE; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

AGED; AGING; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONSTIPATION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; FALLING; GOUT; HEALTH PRACTITIONER; HEALTH SERVICE; HEART ARRHYTHMIA; HEART BLOCK; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; OUTPATIENT; PEPTIC ULCER; PREVALENCE; PROSTATE HYPERTROPHY; RISK ASSESSMENT; SIDE EFFECT;

AGED; ASPIRIN; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; PREVALENCE; VETERANS;

EID: 33748561200     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.08.006     Document Type: Article

References (64)

1. Lindblad C.I., Gray S.L., Guay D.R., et al. Geriatrics. In: Dipiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: A Pathophysiologic Approach. 6th ed. (2005), McGraw-Hill, New York, NY 103-113
2. Chin M.H., Wang L.C., Jin L., et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 6 (1999) 1232-1242
3. Giron M.S., Wang H.X., Bernsten C., et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 49 (2001) 277-283
4. Gosney M., and Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 2 (1984) 564-567
5. Hanlon J.T., Schmader K.E., Boult C., et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 50 (2002) 26-34
6. Kirking D.M., and Ascione F.J. Evaluating variables associated with potential drug-related problems in an older population. J Geriatr Drug Ther 9 (1995) 29-45
7. Fried L.P., and Walston J. Frailty and failure to thrive. In: Hazzard W.R., Blass J.P., Halter J.B., et al. (Eds). Principles of Geriatric Medicine and Gerontology. 5th ed. (2003), McGraw-Hill, New York, NY 1487-1502
8. Hanlon J.T., Fillenbaum G.G., Kuchibhatla M., et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 40 (2002) 166-176
9. Fillenbaum G.G., Hanlon J.T., Landerman L.R., et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2 (2004) 92-101
10. United States Pharmacopeia Dispensing Information (USP DI). 24th ed. (2004), USP, Rockville, Md
11. Malone D.C., Abarca J., Hansten P.D., et al. Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (Wash DC) 44 (2004) 142-151
12. Beers M.H., Ouslander J.G., Rollingher I., et al., UCLA Division of Geriatric Medicine. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 151 (1991) 1825-1832
13. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157 (1997) 1531-1536
14. [published correction appears in Arch Intern Med. 2004; 164:298]. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 163 (2003) 2716-2724
15. Knight E.L., and Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 135 (2001) 703-710
16. MacKinnon N.J., and Hepler C.D. Preventable drug-related morbidity in older adults 1. Indicator development. J Manag Care Pharm 8 (2002) 365-371
17. McLeod P.J., Huang A.R., Tamblyn R.M., and Gayton D.C. Defining inappropriate practices in prescribing for elderly people: A national consensus panel. CMAJ 156 (1997) 385-391
18. Morris C.J., Cantrill J.A., Hepler C.D., and Noyce P.R. Preventing drug-related morbidity-determining valid indicators. Int J Qual Health Care 14 (2002) 183-198
19. Batty G.M., Oborne C.A., Swift C.G., and Jackson S.H. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients. Int J Geriatr Psychiatry 15 (2000) 892-896
20. Belton K., and Thomas S.H. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Postgrad Med J 75 (1999) 509-510
21. Cherin P., Colvez A., Deville de Periere G., and Sereni D. Risk of syncope in the elderly and consumption of drugs: A case-control study. J Clin Epidemiol 50 (1997) 313-320
22. Diokno A.C., Brown M.B., and Herzog A.R. Relationship between use of diuretics and continence status in the elderly. Urology 38 (1991) 39-42
23. Dougall H.T., and McLay J. A comparative review of the adverse effects of calcium antagonists. Drug Saf 15 (1996) 91-106
24. Evans J.M., Hayes J.L., Lipworth B.J., and MacDonald T.M. Potentially hazardous co-prescribing of beta adrenoceptor antagonists and agonists in the community. Br J Gen Pract 46 (1996) 423-425
25. Golden A.G., Petropoulos J.B., Silverman M.A., et al. The use of oral nutritional supplements and anorexi genic medications in homebound older adults. J Am Geriatr Soc 51 (2003) 724-726
26. Gormley E.A., Griffiths D.J., McCracken P.N., and Harrison G.M. Polypharmacy and its effect on urinary incontinence in a geriatric population. Br J Urol 71 (1993) 265-269
27. Gray S.L., Lai K.V., and Larson E.B. Drug induced cognition disorders in the elderly: Incidence, prevention and man agement. Drug Saf 21 (1999) 101-122
28. Hashimoto M., Imamura T., Tanimukai S., et al. Urinary incontinence: An unrecognised adverse effect with conepezil. Lancet 356 (2000) 568
29. Ko D.T., Hebert P.R., Coffey C.S., et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288 (2002) 351-357
30. Kotylar M., Gray S.L., Lindblad C.I., and Hanlon J.T. Psychiatric manifestations of medications in the elderly. In: Malletta G., and Agronin M. (Eds). Principles and Practice of Geriatric Psychiatry (2005), Lippincott, Williams & Wilkins, Philadelphia, Pa 605-615
31. Lanci F., Cesari M., Russo A., et al., Silvernet-HC Study Group. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther 72 (2002) 729-734
32. Leipzig R.M., Cumming R.G., and Tinetti M.E. Drugs and falls in older people: A systematic review and meta analysis: I. Psychotropic drugs. J Am Geriatr Soc 47 (1999) 30-39
33. Lindblad C.I., Artz M.B., Pieper C.F., et al. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 39 (2005) 412-417
34. Luna B., and Feinglos M.N. Drug-induced hyperglycemia. JAMA 286 (2001) 1945-1948
35. Mort J. Medications exacerbating urinary incontinence in the elderly. S D J Med 50 (1997) 361-362
36. Movig K.L., Leuflkens H.G., Belitser S.V., et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 11 (2002) 271-279
37. Ouslander J.G. Management of overactive bladder. N Engl J Med 350 (2004) 786-799
38. Patten S.B., and Love E.J. Drug-induced depression. Psychother Psychosom 66 (1997) 63-73
39. Pisani F., Oteri G., Costa C., et al. Effects of psychotropic drugs on seizure threshold. Drug Saf 25 (2002) 91-110
40. Romanowski G.L., Shimp L.A., Balson A.B., and Cahn M.I. Urinary incontinence in the elderly: Etiology and treat ment. Drug Intell Clin Pharm 22 (1988) 525-533
41. Ruby C.M., Fillenbaum G.G., Kuchibhatla M.N., and Hanlon J.T. Laxative use in the community-dwelling elderly. Am J Geriatr Pharmacother 1 (2003) 1117
42. Steele A.C., Kohli N., Mallipeddi P., and Karram M. Pharmacologic causes of female incontinence. Int Urogynecol J Pelvic Floor Dysfunct 10 (1999) 106-110
43. Tripathi R.C., Tripathi B.J., and Haggerty C. Drug-induced glaucomas: Mechanism and management. Drug Saf 26 (2003) 749-767
44. Drugs for pain. Treat Guidel Med Lett 2 (2004) 47-54
45. Valuck R.J., Perlman J.I., Anderson C., and Wortman G.I. Co-prescribing of medications used to treat obstruc tive lung disease, congestive heart failure and depression among users of topical beta blockers: Estimates from three US Veterans Affairs Medical Centers. Pharmacoepidemiol Drug Saf 10 (2001) 511-516
46. Fouts M., Hanlon J., Pieper C., et al. Identification of elderly nursing facility residents at high risk for drug related problems. Consult Pharm 12 (1997) 1103-1111
47. Hajjar E.R., Hanlon J.T., Artz M.B., et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1 (2003) 82-89
48. Jones J., and Hunter D. Consensus methods for medical and health services research. BMJ 311 (1995) 376-380
49. McGlynn E.A., and Asch S.M. Developing a clinical performance measure. Am J Prev Med 14 Suppl 3 (1998) 14-21
50. Schmader K.E., Hanlon J.T., Pieper C.F., et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116 (2004) 394-401
51. Hanlon J.T., Fillenbaum G.G., Burchett B., et al. Drug use patterns in black and nonblack community-dwelling elderly. Ann Pharmacother 26 (1992) 679-685
52. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
53. Rosner B. Fundamentals of Biostatistics. 3rd ed. (1990), PWS-Kent Publishing Company, Boston, Mass
54. Edwards R.F., Harrison T.M., and Davis S.M. Potentially inappropriate prescribing for geriatric inpatients: An acute care of the elderly unit compared to a general medicine service. Consult Pharm 18 (2003) 37-42
55. Edwards R.F., Harrison T.M., and Davis S.M. Potentially inappropriate prescribing for geriatric inpatients: An acute care of the elderly unit compared to a general medicine service. Consult Pharm 18 (2003) 47-49
56. Mulsant B.H., Pollock B.G., Kirshner M., et al. Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance. Arch Gen Psychiatry 60 (2003) 198-203
57. Roe C.M., Anderson M.J., and Spivack B. Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc 50 (2002) 836-842
58. Carnahan R.M., Lund B.C., Perry P.J., and Chrischilles E.A. The concurrent use of anticholinergics and cholinester ase inhibitors: Rare event or common practice?. J Am Geriatr Soc 52 (2004) 2082-2087
59. Wang P.S., Bohn R.L., Glynn R.J., et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 49 (2001) 1685-1690
60. Stevens J.C., and Pollack M.H. Benzodiazepines in clinical practice: Consideration of their long-term use and alternative agents. J Clin Psychiatry 66 Suppl 2 (2005) 21-27
61. Fink H., Wyman J., and Hanlon J.T. Falls. In: Tallis R., and Fillit H. (Eds). Brocklehurst's Textbook of Geriatric Medicine. 6th ed. (2003), Churchill Livingstone, London, UK 1337-1346
62. Hienle T.T., Cumming R.G., Cameron I.D., et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc 53 (2005) 1290-1295
63. Hanlon J.T., Guay D.R., and Ives T. Oral analgesics: Efficacy, mechanism of action, pharmacokinetics, adverse effects, drug interactions, and practical recommendations for use in older adults. In: Gibson S.J., and Weiner D.K. (Eds). Pain in Older Persons, Progress in Pain Research and Management Vol 35 (2005), IASP Press, Seattle, Wash 205-222
64. Wilchesky M., Tamblyn R.M., and Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 57 (2004) 131-141